Novo Nordisk A/S ADR buy Quitte
Start price
15.08.16
/
50%
€42.14
Target price
15.02.17
€44.65
Performance (%)
-26.05%
End price
15.02.17
€31.16
Summary
This prediction ended on 15.02.17 with a price of €31.16. The prediction for Novo Nordisk A/S ADR disappointed with a performance of -26.05%. Quitte has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Novo Nordisk A/S ADR | 2.510% | 2.510% | -20.712% | 87.883% |
iShares Core DAX® | -0.051% | 4.829% | 17.062% | 18.811% |
iShares Nasdaq 100 | 1.659% | 2.417% | 38.705% | 56.555% |
iShares Nikkei 225® | 0.658% | -2.173% | 13.159% | 7.768% |
iShares S&P 500 | 0.964% | 2.547% | 30.492% | 47.355% |
Comments by Quitte for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
übertrieben
sooo schrecklich waren die Zahlen nicht
Analysten bleiben positiv
(Laufzeit überschritten)